54 optimization-nonlinear-functions Fellowship positions at University of Birmingham in Uk
-
decision making on appropriate amendments to experimental design and progress to ensure optimal output. Plan for the use of research resources as appropriate. Contribute to the planning of research projects
-
becoming standard practice. However, achieving formal assurance of software correctness remains a complex challenge. Seminal work in programming language semantics provides powerful frameworks
-
starting salary is normally in the range £36,130 to £45,413 with potential progression once in post to £48,149 Grade: 7 Part Time (30 hours per week) Fixed Term contract up to July 2027 Closing date: 11th
-
September 2025 Background This focus of this role is on exploring how health impact assessment can applied to mobility decarbonisation scenarios in UK and US city regions, in particular considering
-
candidate will work in translational immunology to deliver a specific project to understand the biology of lubricin and its role in fibroblast-macrophage crosstalk in lining layer of the synovium under
-
service is based on a trauma-informed, relational, adaptive and strengths-based approach. As part of the Birmingham Pathfinder (BP) Award—fully funded by the JABSS Foundation—the University of Birmingham is
-
, Fixed Term contract up to August 2028 Closing date: 19th August 2025 UK and International travel may be required for this role Background The post holder will be required to carry out computational
-
2025 UK and International travel may be required for this role. Background The School of Geography, Earth and Environmental Sciences at the University of Birmingham (UoB, UK) is offering a fixed-term
-
potential progression once in post to £48,149 Grade: 7 Fixed term contract for up to 42 months: Full time, 37.5 hours per week for three years; then part time, 18.75 hours per week for 6 months. Closing date
-
. Understanding of synovial mechanisms underlying flare is only just starting to emerge thanks to well-designed RACE studies. BioFlare was designed to use conventional DMARD withdrawal from patients in clinical